Amphetamine-type stimulant use, including methamphetamine, has soared among Australian blue-collar workers on the job. This was reported by Qazaqyia.kz citing The Guardian.
The Drug Detection Agency, Australasia's largest workplace drug-testing provider, released its latest report on Thursday for the final quarter of the 2025/26 financial year.
The data shows the ingestion of amphetamine-type stimulants, including methamphetamine, soared over the year among the mostly blue-collar workers who underwent testing.
The presence of amphetamine-type stimulants accounted for 60% of all positive tests in the June quarter, a significant year-on-year rise of 17.9%.
Next in line was the use of opioids, including oxycodone, which made up 11.6% of positive tests, although usage was down over the year.
Cocaine was detected in 8% of positive tests in the quarter, an increase from the same period in the previous year.
Cannabis was also present in 39% of positive tests, but usage fell slightly annually.
Drugs were found in 3% of all screens conducted by the agency, which noted that rate was broadly unchanged from previous quarters.
By jurisdiction, Western Australia recorded the highest use of amphetamine-type stimulants at 88.6%, although the four other mainland states were all pushing 50% or above.
South Australia had the highest cocaine detections, Queensland the highest cannabis detections and Victoria the highest opioid detections.
NSW ranked second for cocaine and opioids, third for cannabis and fourth for meth.